French Evaluation Group

French Evaluation Group (FEG) was a specialized health economics and outcomes research (HEOR) and market access consultancy based in Paris, France. The firm provided strategic advice and technical support to pharmaceutical, biotechnology, and medical device companies, focusing on pricing, reimbursement, and market entry strategies within the European landscape. FEG was particularly recognized for its deep expertise in the French healthcare system, assisting clients in the development of value dossiers and economic models for submission to health technology assessment (HTA) bodies such as the Haute Autorité de Santé (HAS). The company eventually merged into the Creativ-Ceutical group, where its core expertise continues to support global life science firms in demonstrating the clinical and economic value of innovative therapies.